Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_assertion type Assertion NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_head.
- NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_assertion description "[Most were overexpressed in ovarian cancer compared with ovarian surface epithelium and/or inclusion cysts (EpCAM, EZH2, BIRC5) although BIRC5 and EZH2 were expressed as highly in fallopian tube epithelium as in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_provenance.
- NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_assertion evidence source_evidence_literature NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_provenance.
- NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_assertion SIO_000772 21423607 NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_provenance.
- NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_assertion wasDerivedFrom befree-20140225 NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_provenance.
- NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_assertion wasGeneratedBy ECO_0000203 NP209285.RAdJ7SnBxdzJgjNFOcY8eN_S6C9NYCVFXJGAOG4G2K8as130_provenance.